Global Biobanking Software Market Research Report 2025(Status and Outlook)
Description
Report Overview
Biobanking software refers to specialized digital platforms designed to manage, track, and optimize the storage, retrieval, and utilization of biological samples (such as tissues, blood, DNA, and cells) along with their associated data. These solutions integrate functionalities like sample inventory management, chain-of-custody tracking, compliance with regulatory standards (e.g., HIPAA, GDPR), and integration with laboratory information management systems (LIMS) or electronic health records (EHRs). Advanced features may include barcode/RFID tracking, automated workflows, and analytics for sample quality control, ensuring efficiency and accuracy in biobanks supporting research, pharmaceuticals, and clinical diagnostics. The software is critical for maintaining sample integrity, minimizing human error, and facilitating collaboration across institutions, particularly in precision medicine and large-scale genomic studies. The global biobanking software market is experiencing steady growth, driven by increasing demand for personalized medicine, rising biobank automation, and expanding genomic research initiatives. Key market segments include academic research institutes, pharmaceutical companies, and hospitals, with cloud-based solutions gaining traction due to scalability and remote accessibility. North America dominates the market, supported by strong R&D investments and regulatory frameworks, while Asia-Pacific shows high growth potential due to expanding healthcare infrastructure and biobanking initiatives. Major players focus on AI integration, interoperability, and compliance enhancements to address challenges like data security and sample traceability. The market is projected to expand further as biobanks evolve toward precision medicine and population-scale studies.
The global Biobanking Software market size was estimated at USD 500.55 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biobanking Software market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biobanking Software market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biobanking Software market.
Global Biobanking Software Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cell & Co Bioservices
RUCDR Infinite Biologics
Modul-Bio
Csols
Ziath
LabVantage Solutions
Agilent
Brooks Automation
Technidata
CloudLIMS
Krishagni Solutions
Thermo Fisher
Market Segmentation (by Type)
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Market Segmentation (by Application)
Regenerative Medicine
Life Science
Clinical Research
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biobanking Software Market
Overview of the regional outlook of the Biobanking Software Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biobanking Software Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biobanking Software, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Biobanking software refers to specialized digital platforms designed to manage, track, and optimize the storage, retrieval, and utilization of biological samples (such as tissues, blood, DNA, and cells) along with their associated data. These solutions integrate functionalities like sample inventory management, chain-of-custody tracking, compliance with regulatory standards (e.g., HIPAA, GDPR), and integration with laboratory information management systems (LIMS) or electronic health records (EHRs). Advanced features may include barcode/RFID tracking, automated workflows, and analytics for sample quality control, ensuring efficiency and accuracy in biobanks supporting research, pharmaceuticals, and clinical diagnostics. The software is critical for maintaining sample integrity, minimizing human error, and facilitating collaboration across institutions, particularly in precision medicine and large-scale genomic studies. The global biobanking software market is experiencing steady growth, driven by increasing demand for personalized medicine, rising biobank automation, and expanding genomic research initiatives. Key market segments include academic research institutes, pharmaceutical companies, and hospitals, with cloud-based solutions gaining traction due to scalability and remote accessibility. North America dominates the market, supported by strong R&D investments and regulatory frameworks, while Asia-Pacific shows high growth potential due to expanding healthcare infrastructure and biobanking initiatives. Major players focus on AI integration, interoperability, and compliance enhancements to address challenges like data security and sample traceability. The market is projected to expand further as biobanks evolve toward precision medicine and population-scale studies.
The global Biobanking Software market size was estimated at USD 500.55 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Biobanking Software market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Biobanking Software market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Biobanking Software market.
Global Biobanking Software Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cell & Co Bioservices
RUCDR Infinite Biologics
Modul-Bio
Csols
Ziath
LabVantage Solutions
Agilent
Brooks Automation
Technidata
CloudLIMS
Krishagni Solutions
Thermo Fisher
Market Segmentation (by Type)
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
Market Segmentation (by Application)
Regenerative Medicine
Life Science
Clinical Research
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Biobanking Software Market
Overview of the regional outlook of the Biobanking Software Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biobanking Software Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Biobanking Software, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
112 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Biobanking Software
- 1.2 Key Market Segments
- 1.2.1 Biobanking Software Segment by Type
- 1.2.2 Biobanking Software Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Biobanking Software Market Overview
- 2.1 Global Market Overview
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Biobanking Software Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Biobanking Software Product Life Cycle
- 3.3 Global Biobanking Software Revenue Market Share by Company (2020-2025)
- 3.4 Biobanking Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.5 Biobanking Software Company Headquarters, Area Served, Product Type
- 3.6 Biobanking Software Market Competitive Situation and Trends
- 3.6.1 Biobanking Software Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Biobanking Software Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Biobanking Software Value Chain Analysis
- 4.1 Biobanking Software Value Chain Analysis
- 4.2 Midstream Market Analysis
- 4.3 Downstream Customer Analysis
- 5 The Development and Dynamics of Biobanking Software Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Biobanking Software Market Porter's Five Forces Analysis
- 6 Biobanking Software Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Biobanking Software Market Size Market Share by Type (2020-2025)
- 6.3 Global Biobanking Software Market Size Growth Rate by Type (2021-2025)
- 7 Biobanking Software Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Biobanking Software Market Size (M USD) by Application (2020-2025)
- 7.3 Global Biobanking Software Sales Growth Rate by Application (2020-2025)
- 8 Biobanking Software Market Segmentation by Region
- 8.1 Global Biobanking Software Market Size by Region
- 8.1.1 Global Biobanking Software Market Size by Region
- 8.1.2 Global Biobanking Software Market Size Market Share by Region
- 8.2 North America
- 8.2.1 North America Biobanking Software Market Size by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Biobanking Software Market Size by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Spain
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Biobanking Software Market Size by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Biobanking Software Market Size by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Biobanking Software Market Size by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Cell and Co Bioservices
- 9.1.1 Cell and Co Bioservices Basic Information
- 9.1.2 Cell and Co Bioservices Biobanking Software Product Overview
- 9.1.3 Cell and Co Bioservices Biobanking Software Product Market Performance
- 9.1.4 Cell and Co Bioservices SWOT Analysis
- 9.1.5 Cell and Co Bioservices Business Overview
- 9.1.6 Cell and Co Bioservices Recent Developments
- 9.2 RUCDR Infinite Biologics
- 9.2.1 RUCDR Infinite Biologics Basic Information
- 9.2.2 RUCDR Infinite Biologics Biobanking Software Product Overview
- 9.2.3 RUCDR Infinite Biologics Biobanking Software Product Market Performance
- 9.2.4 RUCDR Infinite Biologics SWOT Analysis
- 9.2.5 RUCDR Infinite Biologics Business Overview
- 9.2.6 RUCDR Infinite Biologics Recent Developments
- 9.3 Modul-Bio
- 9.3.1 Modul-Bio Basic Information
- 9.3.2 Modul-Bio Biobanking Software Product Overview
- 9.3.3 Modul-Bio Biobanking Software Product Market Performance
- 9.3.4 Modul-Bio SWOT Analysis
- 9.3.5 Modul-Bio Business Overview
- 9.3.6 Modul-Bio Recent Developments
- 9.4 Csols
- 9.4.1 Csols Basic Information
- 9.4.2 Csols Biobanking Software Product Overview
- 9.4.3 Csols Biobanking Software Product Market Performance
- 9.4.4 Csols Business Overview
- 9.4.5 Csols Recent Developments
- 9.5 Ziath
- 9.5.1 Ziath Basic Information
- 9.5.2 Ziath Biobanking Software Product Overview
- 9.5.3 Ziath Biobanking Software Product Market Performance
- 9.5.4 Ziath Business Overview
- 9.5.5 Ziath Recent Developments
- 9.6 LabVantage Solutions
- 9.6.1 LabVantage Solutions Basic Information
- 9.6.2 LabVantage Solutions Biobanking Software Product Overview
- 9.6.3 LabVantage Solutions Biobanking Software Product Market Performance
- 9.6.4 LabVantage Solutions Business Overview
- 9.6.5 LabVantage Solutions Recent Developments
- 9.7 Agilent
- 9.7.1 Agilent Basic Information
- 9.7.2 Agilent Biobanking Software Product Overview
- 9.7.3 Agilent Biobanking Software Product Market Performance
- 9.7.4 Agilent Business Overview
- 9.7.5 Agilent Recent Developments
- 9.8 Brooks Automation
- 9.8.1 Brooks Automation Basic Information
- 9.8.2 Brooks Automation Biobanking Software Product Overview
- 9.8.3 Brooks Automation Biobanking Software Product Market Performance
- 9.8.4 Brooks Automation Business Overview
- 9.8.5 Brooks Automation Recent Developments
- 9.9 Technidata
- 9.9.1 Technidata Basic Information
- 9.9.2 Technidata Biobanking Software Product Overview
- 9.9.3 Technidata Biobanking Software Product Market Performance
- 9.9.4 Technidata Business Overview
- 9.9.5 Technidata Recent Developments
- 9.10 CloudLIMS
- 9.10.1 CloudLIMS Basic Information
- 9.10.2 CloudLIMS Biobanking Software Product Overview
- 9.10.3 CloudLIMS Biobanking Software Product Market Performance
- 9.10.4 CloudLIMS Business Overview
- 9.10.5 CloudLIMS Recent Developments
- 9.11 Krishagni Solutions
- 9.11.1 Krishagni Solutions Basic Information
- 9.11.2 Krishagni Solutions Biobanking Software Product Overview
- 9.11.3 Krishagni Solutions Biobanking Software Product Market Performance
- 9.11.4 Krishagni Solutions Business Overview
- 9.11.5 Krishagni Solutions Recent Developments
- 9.12 Thermo Fisher
- 9.12.1 Thermo Fisher Basic Information
- 9.12.2 Thermo Fisher Biobanking Software Product Overview
- 9.12.3 Thermo Fisher Biobanking Software Product Market Performance
- 9.12.4 Thermo Fisher Business Overview
- 9.12.5 Thermo Fisher Recent Developments
- 10 Biobanking Software Market Forecast by Region
- 10.1 Global Biobanking Software Market Size Forecast
- 10.2 Global Biobanking Software Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Biobanking Software Market Size Forecast by Country
- 10.2.3 Asia Pacific Biobanking Software Market Size Forecast by Region
- 10.2.4 South America Biobanking Software Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Sales of Biobanking Software by Country
- 11 Forecast Market by Type and by Application (2026-2033)
- 11.1 Global Biobanking Software Market Forecast by Type (2026-2033)
- 11.2 Global Biobanking Software Market Forecast by Application (2026-2033)
- 12 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
